Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease - PubMed (original) (raw)
Review
Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease
M G Murer et al. Prog Neurobiol. 2001 Jan.
Abstract
Brain-derived neurotrophic factor (BDNF) is a small dimeric protein, structurally related to nerve growth factor, which is abundantly and widely expressed in the adult mammalian brain. BDNF has been found to promote survival of all major neuronal types affected in Alzheimer's disease and Parkinson's disease, like hippocampal and neocortical neurons, cholinergic septal and basal forebrain neurons, and nigral dopaminergic neurons. In this article, we summarize recent work on the molecular and cellular biology of BDNF, including current ideas about its intracellular trafficking, regulated synthesis and release, and actions at the synaptic level, which have considerably expanded our conception of BDNF actions in the central nervous system. But our primary aim is to review the literature regarding BDNF distribution in the human brain, and the modifications of BDNF expression which occur in the brain of individuals with Alzheimer's disease and Parkinson's disease. Our knowledge concerning BDNF actions on the neuronal populations affected in these pathological states is also reviewed, with an aim at understanding its pathogenic and pathophysiological relevance.
Similar articles
- An immunohistochemical study of the distribution of brain-derived neurotrophic factor in the adult human brain, with particular reference to Alzheimer's disease.
Murer MG, Boissiere F, Yan Q, Hunot S, Villares J, Faucheux B, Agid Y, Hirsch E, Raisman-Vozari R. Murer MG, et al. Neuroscience. 1999;88(4):1015-32. doi: 10.1016/s0306-4522(98)00219-x. Neuroscience. 1999. PMID: 10336117 - Molecular mechanisms of brain-derived neurotrophic factor in neuro-protection: Recent developments.
Zhao H, Alam A, San CY, Eguchi S, Chen Q, Lian Q, Ma D. Zhao H, et al. Brain Res. 2017 Jun 15;1665:1-21. doi: 10.1016/j.brainres.2017.03.029. Epub 2017 Apr 7. Brain Res. 2017. PMID: 28396009 Review. - Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: decreased levels in Alzheimer's disease.
Holsinger RM, Schnarr J, Henry P, Castelo VT, Fahnestock M. Holsinger RM, et al. Brain Res Mol Brain Res. 2000 Mar 29;76(2):347-54. doi: 10.1016/s0169-328x(00)00023-1. Brain Res Mol Brain Res. 2000. PMID: 10762711 - Recent Advances on the Role of Brain-Derived Neurotrophic Factor (BDNF) in Neurodegenerative Diseases.
Azman KF, Zakaria R. Azman KF, et al. Int J Mol Sci. 2022 Jun 19;23(12):6827. doi: 10.3390/ijms23126827. Int J Mol Sci. 2022. PMID: 35743271 Free PMC article. Review. - Pro-brain-derived neurotrophic factor is decreased in parietal cortex in Alzheimer's disease.
Michalski B, Fahnestock M. Michalski B, et al. Brain Res Mol Brain Res. 2003 Mar 17;111(1-2):148-54. doi: 10.1016/s0169-328x(03)00003-2. Brain Res Mol Brain Res. 2003. PMID: 12654514
Cited by
- Clinical and Neurobiological Relevance of Current Animal Models of Autism Spectrum Disorders.
Kim KC, Gonzales EL, Lázaro MT, Choi CS, Bahn GH, Yoo HJ, Shin CY. Kim KC, et al. Biomol Ther (Seoul). 2016 May 1;24(3):207-43. doi: 10.4062/biomolther.2016.061. Biomol Ther (Seoul). 2016. PMID: 27133257 Free PMC article. Review. - Activation of TrkB-Akt signaling rescues deficits in a mouse model of SCA6.
Cook AA, Jayabal S, Sheng J, Fields E, Leung TCS, Quilez S, McNicholas E, Lau L, Huang S, Watt AJ. Cook AA, et al. Sci Adv. 2022 Sep 16;8(37):eabh3260. doi: 10.1126/sciadv.abh3260. Epub 2022 Sep 16. Sci Adv. 2022. PMID: 36112675 Free PMC article. - Brain-derived neurotrophic factor gene-modified bone marrow mesenchymal stem cells.
Han ZM, Huang HM, Wang FF. Han ZM, et al. Exp Ther Med. 2015 Feb;9(2):519-522. doi: 10.3892/etm.2014.2113. Epub 2014 Dec 8. Exp Ther Med. 2015. PMID: 25574226 Free PMC article. - Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer's pathology.
Tesseur I, Zou K, Esposito L, Bard F, Berber E, Can JV, Lin AH, Crews L, Tremblay P, Mathews P, Mucke L, Masliah E, Wyss-Coray T. Tesseur I, et al. J Clin Invest. 2006 Nov;116(11):3060-9. doi: 10.1172/JCI27341. J Clin Invest. 2006. PMID: 17080199 Free PMC article. - Physical Activity and Its Diurnal Fluctuations Vary by Non-Motor Symptoms in Patients with Parkinson's Disease: An Exploratory Study.
Nagaki K, Fujioka S, Sasai H, Yamaguchi Y, Tsuboi Y. Nagaki K, et al. Healthcare (Basel). 2022 Apr 18;10(4):749. doi: 10.3390/healthcare10040749. Healthcare (Basel). 2022. PMID: 35455926 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical